Home › Cancro al rene (carcinoma a cellule renali) › Florida
Studi clinici su Cancro al rene (carcinoma a cellule renali) nello stato di Florida
31 studi su Cancro al rene (carcinoma a cellule renali) cercano partecipanti presso sedi nello stato di Florida.
Città nello stato di Florida
Testo ufficiale dello studio (inglese)
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Research Site, Miami
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT05536141Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- NEO-811 Florida Site, Miami
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT07300241Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06265285A Phase 1 Study of the Safety and Tolerability of CTX-10726
- Mayo Clinic Florida, Jacksonville
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07419841Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- e altri 11
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #48, Celebration
- Exelixis Clinical Site #11, Gainesville
- Exelixis Clinical Site #78, Jacksonville
- e altri 2
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT05176483The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07285044Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Holy Cross Hospital, Fort Lauderdale
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT03866382REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
- H. Lee Moffitt Cancer Center, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07594106DESTINY-PANTUMOUR04
- Research Site, Coral Springs
- Research Site, St. Petersburg
- Research Site, West Palm Beach
In reclutamentoStudio osservazionale
Età da 18 a 130 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07124000Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT04981119Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06047379A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Local Institution - 0177, Miami
- Local Institution - 0126, Orlando
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07293351Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Sylvester Comprehensive Cancer Center - Miami, Miami
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT05267626Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Mayo Clinic in Florida, Jacksonville
- e altri 3
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT05327686Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Mayo Clinic Pharmacy, Jacksonville
- Orlando Health Ambulatory Care Center, Orlando
- Orlando Health Cancer Institute, Orlando
- e altri 1
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07227415ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Memorial Healthcare System, Hollywood
- The Oncology Institute of Hope & Innovation, Lakeland
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT05059444Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- UF Health Cancer Institute - Gainesville, Gainesville
- Miami Cancer Institute, Miami
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06661720Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 1/2
Età 16 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT05269381Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Jacksonville
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT05433142Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT04198766A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center - McKinley Drive, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2026 · NCT03972657KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- AdventHealth Celebration, Celebration
- Mayo Clinic Comprehensive Cancer Center, Jacksonville
- Florida Cancer Specialists, Sarasota
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 giu 2026 · NCT06026410A Study of VET3-TGI in Patients With Solid Tumors
- University of Miami, Miami
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 apr 2026 · NCT06444815Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Florida, Jacksonville
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT06349642A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Mayo Clinic, Jacksonville
- Moffitt Cancer Center, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2025 · NCT06682793Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- AdventHealth Altamonte, Altamonte Springs
- AdventHealth Celebration, Celebration
- AdventHealth Kissimmee, Kissimmee
- e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2025 · NCT04510597A Beta-only IL-2 ImmunoTherapY Study
- Boca Raton Regional Hospital, Boca Raton
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2025 · NCT05086692A Study of IBI363 in Subjects with Advanced Solid Malignancies
- Ocala Oncology Center, Ocala
- BRCR Medical Center, Plantation
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 dic 2024 · NCT06281678A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 nov 2024 · NCT05824975Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Moffitt Cancer Center, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 nov 2024 · NCT04787042Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.